Sone Capital Management LLC acquired a new stake in shares of Revvity Inc. (NYSE:RVTY – Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 109,761 shares of the company’s stock, valued at approximately $12,212,000. Sone Capital Management LLC owned about 0.10% of Revvity as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors also recently bought and sold shares of RVTY. New Mexico Educational Retirement Board boosted its position in Revvity by 1.9% in the fourth quarter. New Mexico Educational Retirement Board now owns 5,416 shares of the company’s stock worth $524,000 after purchasing an additional 100 shares during the last quarter. Allworth Financial LP increased its position in shares of Revvity by 8.9% during the 4th quarter. Allworth Financial LP now owns 1,275 shares of the company’s stock valued at $123,000 after purchasing an additional 104 shares during the last quarter. EverSource Wealth Advisors LLC lifted its stake in shares of Revvity by 17.0% in the 1st quarter. EverSource Wealth Advisors LLC now owns 749 shares of the company’s stock worth $66,000 after purchasing an additional 109 shares during the period. HighTower Advisors LLC lifted its stake in shares of Revvity by 2.6% in the 4th quarter. HighTower Advisors LLC now owns 5,141 shares of the company’s stock worth $497,000 after purchasing an additional 129 shares during the period. Finally, Cary Street Partners Financial LLC boosted its holdings in shares of Revvity by 1.6% in the fourth quarter. Cary Street Partners Financial LLC now owns 8,941 shares of the company’s stock worth $865,000 after buying an additional 141 shares during the last quarter. Institutional investors own 86.65% of the company’s stock.
Revvity Price Performance
NYSE RVTY opened at $123.08 on Tuesday. The company has a current ratio of 1.80, a quick ratio of 1.50 and a debt-to-equity ratio of 0.36. Revvity Inc. has a 12 month low of $81.22 and a 12 month high of $124.97. The stock has a market cap of $13.73 billion, a price-to-earnings ratio of 58.61, a PEG ratio of 2.27 and a beta of 1.07. The company’s 50 day moving average is $111.90 and its two-hundred day moving average is $100.48.
Revvity Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Friday, October 23rd will be issued a $0.07 dividend. The ex-dividend date of this dividend is Friday, October 23rd. This represents a $0.28 annualized dividend and a yield of 0.2%. Revvity’s dividend payout ratio is currently 13.33%.
Wall Street Analysts Forecast Growth
Several analysts recently issued reports on the stock. Wall Street Zen lowered shares of Revvity from a “buy” rating to a “hold” rating in a research report on Sunday, August 16th. Stifel Nicolaus dropped their price target on shares of Revvity from $110.00 to $100.00 and set a “hold” rating on the stock in a research note on Wednesday, May 6th. Robert W. Baird set a $117.00 price objective on shares of Revvity in a research report on Wednesday, May 6th. TD Cowen restated a “buy” rating on shares of Revvity in a research note on Wednesday, July 15th. Finally, Sanford C. Bernstein initiated coverage on Revvity in a report on Friday, June 26th. They issued a “market perform” rating and a $115.00 target price on the stock. Three equities research analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the stock. According to MarketBeat, Revvity has a consensus rating of “Hold” and an average target price of $108.36.
View Our Latest Report on Revvity
About Revvity
Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.
Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.
Further Reading
- Five stocks we like better than Revvity
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Want to see what other hedge funds are holding RVTY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Revvity Inc. (NYSE:RVTY – Free Report).
Receive News & Ratings for Revvity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revvity and related companies with MarketBeat.com's FREE daily email newsletter.
